Current File : /var/www/html/rental/storage/8h9evw5q/cache/7bf8d4cc406773959726fb38469f0afc
a:5:{s:8:"template";s:8837:"<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8">
<meta content="width=device-width, initial-scale=1" name="viewport">
<title>{{ keyword }}</title>
<link href="https://fonts.googleapis.com/css?family=Roboto+Condensed%3A300italic%2C400italic%2C700italic%2C400%2C300%2C700%7CRoboto%3A300%2C400%2C400i%2C500%2C700%7CTitillium+Web%3A400%2C600%2C700%2C300&subset=latin%2Clatin-ext" id="news-portal-fonts-css" media="all" rel="stylesheet" type="text/css">
<style rel="stylesheet" type="text/css">@charset "utf-8";.has-drop-cap:not(:focus):first-letter{float:left;font-size:8.4em;line-height:.68;font-weight:100;margin:.05em .1em 0 0;text-transform:uppercase;font-style:normal}.has-drop-cap:not(:focus):after{content:"";display:table;clear:both;padding-top:14px} body{margin:0;padding:0}@font-face{font-family:Roboto;font-style:italic;font-weight:400;src:local('Roboto Italic'),local('Roboto-Italic'),url(https://fonts.gstatic.com/s/roboto/v20/KFOkCnqEu92Fr1Mu51xGIzc.ttf) format('truetype')}@font-face{font-family:Roboto;font-style:normal;font-weight:300;src:local('Roboto Light'),local('Roboto-Light'),url(https://fonts.gstatic.com/s/roboto/v20/KFOlCnqEu92Fr1MmSU5fChc9.ttf) format('truetype')}@font-face{font-family:Roboto;font-style:normal;font-weight:400;src:local('Roboto'),local('Roboto-Regular'),url(https://fonts.gstatic.com/s/roboto/v20/KFOmCnqEu92Fr1Mu7GxP.ttf) format('truetype')}@font-face{font-family:Roboto;font-style:normal;font-weight:500;src:local('Roboto Medium'),local('Roboto-Medium'),url(https://fonts.gstatic.com/s/roboto/v20/KFOlCnqEu92Fr1MmEU9fChc9.ttf) format('truetype')}@font-face{font-family:Roboto;font-style:normal;font-weight:700;src:local('Roboto Bold'),local('Roboto-Bold'),url(https://fonts.gstatic.com/s/roboto/v20/KFOlCnqEu92Fr1MmWUlfChc9.ttf) format('truetype')} a,body,div,h4,html,li,p,span,ul{border:0;font-family:inherit;font-size:100%;font-style:inherit;font-weight:inherit;margin:0;outline:0;padding:0;vertical-align:baseline}html{font-size:62.5%;overflow-y:scroll;-webkit-text-size-adjust:100%;-ms-text-size-adjust:100%}*,:after,:before{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}body{background:#fff}footer,header,nav,section{display:block}ul{list-style:none}a:focus{outline:0}a:active,a:hover{outline:0}body{color:#3d3d3d;font-family:Roboto,sans-serif;font-size:14px;line-height:1.8;font-weight:400}h4{clear:both;font-weight:400;font-family:Roboto,sans-serif;line-height:1.3;margin-bottom:15px;color:#3d3d3d;font-weight:700}p{margin-bottom:20px}h4{font-size:20px}ul{margin:0 0 15px 20px}ul{list-style:disc}a{color:#029fb2;text-decoration:none;transition:all .3s ease-in-out;-webkit-transition:all .3s ease-in-out;-moz-transition:all .3s ease-in-out}a:active,a:focus,a:hover{color:#029fb2}a:focus{outline:thin dotted}.mt-container:after,.mt-container:before,.np-clearfix:after,.np-clearfix:before,.site-content:after,.site-content:before,.site-footer:after,.site-footer:before,.site-header:after,.site-header:before{content:'';display:table}.mt-container:after,.np-clearfix:after,.site-content:after,.site-footer:after,.site-header:after{clear:both}.widget{margin:0 0 30px}body{font-weight:400;overflow:hidden;position:relative;font-family:Roboto,sans-serif;line-height:1.8}.mt-container{width:1170px;margin:0 auto}#masthead .site-branding{float:left;margin:20px 0}.np-logo-section-wrapper{padding:20px 0}.site-title{font-size:32px;font-weight:700;line-height:40px;margin:0}.np-header-menu-wrapper{background:#029fb2 none repeat scroll 0 0;margin-bottom:20px;position:relative}.np-header-menu-wrapper .mt-container{position:relative}.np-header-menu-wrapper .mt-container::before{background:rgba(0,0,0,0);content:"";height:38px;left:50%;margin-left:-480px;opacity:1;position:absolute;top:100%;width:960px}#site-navigation{float:left}#site-navigation ul{margin:0;padding:0;list-style:none}#site-navigation ul li{display:inline-block;line-height:40px;margin-right:-3px;position:relative}#site-navigation ul li a{border-left:1px solid rgba(255,255,255,.2);border-right:1px solid rgba(0,0,0,.08);color:#fff;display:block;padding:0 15px;position:relative;text-transform:capitalize}#site-navigation ul li:hover>a{background:#028a9a}#site-navigation ul#primary-menu>li:hover>a:after{border-bottom:5px solid #fff;border-left:5px solid transparent;border-right:5px solid transparent;bottom:0;content:"";height:0;left:50%;position:absolute;-webkit-transform:translateX(-50%);-ms-transform:translateX(-50%);-moz-transform:translateX(-50%);transform:translateX(-50%);width:0}.np-header-menu-wrapper::after,.np-header-menu-wrapper::before{background:#029fb2 none repeat scroll 0 0;content:"";height:100%;left:-5px;position:absolute;top:0;width:5px;z-index:99}.np-header-menu-wrapper::after{left:auto;right:-5px;visibility:visible}.np-header-menu-block-wrap::after,.np-header-menu-block-wrap::before{border-bottom:5px solid transparent;border-right:5px solid #03717f;border-top:5px solid transparent;bottom:-6px;content:"";height:0;left:-5px;position:absolute;width:5px}.np-header-menu-block-wrap::after{left:auto;right:-5px;transform:rotate(180deg);visibility:visible}.np-header-search-wrapper{float:right;position:relative}.widget-title{background:#f7f7f7 none repeat scroll 0 0;border:1px solid #e1e1e1;font-size:16px;margin:0 0 20px;padding:6px 20px;text-transform:uppercase;border-left:none;border-right:none;color:#029fb2;text-align:left}#colophon{background:#000 none repeat scroll 0 0;margin-top:40px}#top-footer{padding-top:40px}#top-footer .np-footer-widget-wrapper{margin-left:-2%}#top-footer .widget li::hover:before{color:#029fb2}#top-footer .widget-title{background:rgba(255,255,255,.2) none repeat scroll 0 0;border-color:rgba(255,255,255,.2);color:#fff}.bottom-footer{background:rgba(255,255,255,.1) none repeat scroll 0 0;color:#bfbfbf;font-size:12px;padding:10px 0}.site-info{float:left}#content{margin-top:30px}@media (max-width:1200px){.mt-container{padding:0 2%;width:100%}}@media (min-width:1000px){#site-navigation{display:block!important}}@media (max-width:979px){#masthead .site-branding{text-align:center;float:none;margin-top:0}}@media (max-width:768px){#site-navigation{background:#029fb2 none repeat scroll 0 0;display:none;left:0;position:absolute;top:100%;width:100%;z-index:99}.np-header-menu-wrapper{position:relative}#site-navigation ul li{display:block;float:none}#site-navigation ul#primary-menu>li:hover>a::after{display:none}}@media (max-width:600px){.site-info{float:none;text-align:center}}</style>
</head>
<body class="wp-custom-logo hfeed right-sidebar fullwidth_layout">
<div class="site" id="page">
<header class="site-header" id="masthead" role="banner"><div class="np-logo-section-wrapper"><div class="mt-container"> <div class="site-branding">
<a class="custom-logo-link" href="{{ KEYWORDBYINDEX-ANCHOR 0 }}" rel="home"></a>
<p class="site-title"><a href="{{ KEYWORDBYINDEX-ANCHOR 1 }}" rel="home">{{ KEYWORDBYINDEX 1 }}</a></p>
</div>
</div></div> <div class="np-header-menu-wrapper" id="np-menu-wrap">
<div class="np-header-menu-block-wrap">
<div class="mt-container">
<nav class="main-navigation" id="site-navigation" role="navigation">
<div class="menu-categorias-container"><ul class="menu" id="primary-menu"><li class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-51" id="menu-item-51"><a href="{{ KEYWORDBYINDEX-ANCHOR 2 }}">{{ KEYWORDBYINDEX 2 }}</a></li>
<li class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-55" id="menu-item-55"><a href="{{ KEYWORDBYINDEX-ANCHOR 3 }}">{{ KEYWORDBYINDEX 3 }}</a></li>
<li class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-57" id="menu-item-57"><a href="{{ KEYWORDBYINDEX-ANCHOR 4 }}">{{ KEYWORDBYINDEX 4 }}</a></li>
<li class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-58" id="menu-item-58"><a href="{{ KEYWORDBYINDEX-ANCHOR 5 }}">{{ KEYWORDBYINDEX 5 }}</a></li>
</ul></div> </nav>
<div class="np-header-search-wrapper">
</div>
</div>
</div>
</div>
</header>
<div class="site-content" id="content">
<div class="mt-container">
{{ text }}
</div>
</div>
<footer class="site-footer" id="colophon" role="contentinfo">
<div class="footer-widgets-wrapper np-clearfix" id="top-footer">
<div class="mt-container">
<div class="footer-widgets-area np-clearfix">
<div class="np-footer-widget-wrapper np-column-wrapper np-clearfix">
<div class="np-footer-widget wow" data-wow-duration="0.5s">
<section class="widget widget_text" id="text-3"><h4 class="widget-title">{{ keyword }}</h4> <div class="textwidget">
{{ links }}
</div>
</section> </div>
</div>
</div>
</div>
</div>
<div class="bottom-footer np-clearfix"><div class="mt-container"> <div class="site-info">
<span class="np-copyright-text">
{{ keyword }} 2021</span>
</div>
</div></div> </footer></div>
</body>
</html>";s:4:"text";s:35361:"<a href="https://atm.amegroups.com/article/view/11382/html">Association of insulin treatment versus oral hypoglycaemic ...</a> The Diabetic Retinopathy Screening Service for Lisbon and Tagus Valley-RETINODIAB-was commissioned and carried out in Portugal between July 2009 and October 2014.5 Data analysis included 52,739 patients with type 2 diabetes, diagnosed over the age of 40 years, 49.6% of whom were women. largely because of demographic and lifestyle changes, sub-saharan africa will be affected by a particularly steep increase in prevalence of dm during the coming years and decades. Review of the peer-reviewed articles in PubMed, Google, and Scirus . This is driven by the rising number of people living with diabetes all over the world, with the largest increases projected in Asia and Africa. Epidemiology and treatment outcomes of diabetic retinopathy in a diabetic population . Diabetic retinopathy segment to expand significantly. RetinaRisk App. Table 2 summarizes cohort studies of diabetic retinopathy conducted in Africa. 1 In sub-Saharan Africa (SSA), diabetes mellitus is estimated to affect 40.7 million people by 2045, up from 15.9 . Bevacizumab as an adjunct to vitreoretinal surgery for diabetic retinopathy in East Africa G Guthrie , 1, 2, 3, * A B Hall , 3 K Dhalla , 3 R M Davis , 1 and D H Steel 2, 4 1 Newcastle University Medical School, Newcastle Upon Tyne, UK Background: The International Diabetes Federation estimates that the number of adults with diabetes in Africa will increase by 98% by the year 2030. Design. Prevalence of diabetic retinopathy ranges from 19% in UAE to 64% in Jordan (Table 1). Showing resolution of hemorrhage and neovascularization following laser pan-retinal photocoagulation. Methods: Subjects from a cohort sampled from a hospital-based, primary-care diabetes clinic in 2007 were traced in 2012. Due to my diabetes and the severity of my retinopathy in the left eye, I had to have my . Diabetes microvascular and macrovascular disease in Africa. 32 Yun YW, Shin MH, Lee YH, Rhee JA, Choi JS. ET bs_bs_banner Journal of Diabetes 6 (2014) 167-175 O R I G I N A L A RT I C L E Oxidants, antioxidants and mitochondrial function in non-proliferative diabetic retinopathy Adolfo Daniel RODRÍGUEZ-CARRIZALEZ,1 José Alberto CASTELLANOS-GONZÁLEZ,3 Esaú César MARTÍNEZ-ROMERO,3 Guillermo MILLER-ARREVILLAGA,3 David VILLA-HERNÁNDEZ,3 Pedro Pablo HERNÁNDEZ-GODÍNEZ,3 Genaro Gabriel ORTIZ,4 . Six of the 10 countries with the highest prevalence of diabetes in the world are from the Middle East (Bahrain, Kuwait, Lebanon, Oman, Saudi Arabia, and United Arab Emirates). In the course of the last 20 years, blindness and low vision due to diabetic eye complications have increased in large regions in Eastern Europe, North Africa/Middle East, Asia, Latin America, and Oceania. Diabet. However, it is the only cause of blindness that showed a global increase in age-standardised prevalence between 1990 and 2020. We report the prevalence of all grades of retinopathy and associations with systemic parameters in patients attending a secondary care diabetes clinic in Blantyre, Malawi. The Diabetic Retinopathy Screening Benefit follows a simple, . 1,094 (15.4%) were referred to a specialist and 546 (8%) referred for laser treatment-44% of diabetes patients in the Cape Town Metropolitan Community Health Centers have their feet examined during routine check-ups. This study assessed the barriers identified by patients and service providers to delivering good services for diabetic retinopathy in Ibadan, Nigeria, Sub-Saharan Africa. Methods The current es-timate for diabetes prevalence in South Africa is 8.3%, very close to the international prevalence [1]. Methods Cross-sectional study of all patients attending for diabetes care in a hospital setting. Artificial Intelligence Using Deep Learning to Screen for Referable and Vision-Threatening Diabetic Retinopathy in Africa. National University of Singapore (NUS) Article content. Diabetic retinopathy can be treated through medicines, laser surgery, and vitrectomy. The global burden of non-communicable disease (NCDs) is staggering, with recent reports highlighting that NCDs are responsible for 73% of deaths globally, with more than 50% of these deaths caused by four risk factors: diabetes, hypertension, obesity, and smoking. 35 Pages Posted: 30 Jan 2019. Mbanya JC, Sobngwi E. Diabetes in Africa. Aims: To describe the incidence and progression of retinopathy in people with diabetes in Southern Malawi over 5 years. 2 diabetes is the third leading cause of blindness in sa, with retinopathy and cataracts 2 accounting for 8 000 new … In Mauritius, in 1998, researchers followed up the population‐based study performed in 1992 with a survey of diabetes complications . Objective: The objective is to determine the pattern and prevalence of diabetic retinopathy (DR) among patients living with diabetes mellitus.Methodology: Descriptive cross-sectional study in a tertiary hospital. Arterial stiffness is 2008;18(1):94-98 associated with diabetic retinopathy in Korean type 2 diabetic patients. DR accounts for approximately 15-17% of all cases of total blindness in the USA and Europe. Purpose: To assess patient preference for diabetic retinopathy (DR) screening with teleophthalmology or face-to-face ophthalmologist evaluation in Nairobi, Kenya. Materials and methods: Fifty seven diabetic patients from a one-stop multidisciplinary diabetic clinic (consisting of a diabetologist, nurse educator, foot specialist, nutritionist, ophthalmologist, and neurologist) in Nairobi, Kenya . There was no . The current study sought to explore factors associated with treatment compliance among patients living with diabetes who . Introduction. Complete patient adherence to treatment for diabetic retinopathy (DR) is critical to limit vision loss. Diabetic retinopathy (DR) is an important cause of vision impairment and blindness in South . The purpose of this systematic review is to identify, collate and synthesise all studies reporting the prevalence of diabetes in South Africa. Estimates of prevalence of diabetic retinopathy, proliferative diabetic retinopathy and maculopathy are comparable with recent European and American studies. Background: Diabetes is an emerging public health problem in sub-Saharan Africa. Diabetic retinopathy appears to take several years (after initial diagnosis) to develop. The prevalence of retinopathy in hospital attending diabetics in Ibadan is reported to be 42 %. Six hundred African diabetic patients were examined using a standardised technique based on the World Health Organisation Multinational Study, in which no country from Africa was represented. 2006;23(5):469-480 8-hydroxydeoxyguanosine levels in diabetic retinopathy patients. Press Release Global Diabetic Retinopathy Drugs Market Audience, Geographies, and Key Players 2022-2027 Published: Nov. 9, 2021 at 12:55 a.m. Keywords: diabetes mellitus, diabetic retinopathy, epidemiology, incidence, risk factors, South Africa Introduction In South Africa, diabetic retinopathy (DR) is the fourth leading cause of blindness, after cataracts, glaucoma and age-related macular degeneration; and visual impairment, after refractive As the diabetes epidemic occurs, there is an imminent increase in visual loss from diabetic retinopathy in the Sub-Saharan Africa.2 There is the problem of poor patient attendance at clinics, non- The natural history of DR and the availability Diabetic retinopathy is the commonest microvascular complication of diabetes and is a leading cause of blindness, mainly in adults of working age. This study provides baseline information on prevalence of all grades of retinopathy and STDR in consecutive cases attending an urban/semi-urban diabetes clinic in sub-Saharan Africa. Prevalence of STDR was high and in type 2 diabetes was associated with albuminuria, neuropathy and insulin use. Introduction Type 2 diabetes mellitus is a major source of morbidity and mortality in South Africa, spurred by increased urbanisation and unhealthy lifestyle factors. Diabetic retinopathy is the smallest contributor to vision loss amongst listed causes in 2020. Follow-up is crucial to the effective management of diabetic retinopathy, however, follow-up rates are often Methods Using a predefined search strategy, we systematically searched MEDLINE, EMBASE, Science Citation index and Conference Proceedings Citation . The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Diabetic Retinopathy Treatment 2016-2021, and development forecast 2022-2027 including industries, major players . Vertice's medium-term strategy is to become the leading specialised MedTech group in South Africa and Sub-Saharan Africa. Oxidized low-density lipoprotein (ox-LDL) is a powerful natural prooxidant derived from native LDL by cell-mediated oxidation. Objectives. Table 1. 30, 399-412 (2013) Introduction The International Diabetes Federation (IDF) has estimated that the number of adults with diabetes in Africa will expand by Med. Aim To summarize findings from studies reporting the prevalence and incidence of diabetic retinopathy and diabetic maculopathy in African countries in light of the rising prevalence of diabetes mellitus. Sub-Saharan Africa (SSA) faces an epidemic of noncommunicable disease (NCD) driven by urbanization, lifestyle, poor diet, smoking, environmental Diabetic retinopathy in sub-Saharan Africa: meeting the challenges of an emerging epidemic | springermedizin.de An AI system shows clinically acceptable performance in detecting referable diabetic retinopathy, vision-threatening diabetic retinopathy, and diabetic macular oedema in population-based diabetic retinopathy screening. The global prevalence of DR was 34.6% [ 6 ], with systematic review estimates in Africa reporting between 30.2% and 31.6% of people with diabetes having DR [ 13 ]. Diabetic retinopathy Diabetic retinopathy (DR) refers to damage and loss of function of the retina (back of the eye) due to uncontrolled diabetes, and without a healthy, functioning retina, the eye cannot see. currently approximately 2 million south africans live with type 2 diabetes, with a projected 115 000 new cases per year. We wanted to discuss about the diagnosis and treatments that have applied in diabetic retinopathy until today and are promising in the next process. Diabetic retinopathy (DR) is a significant global public health and economic burden. They were older and the duration of diabetes was longer than patients without retinopathy or cataract. Living with diabetic retinopathy. We evaluated and compared selected biomarkers of oxidative stress and total antioxidant (TAO) levels in type 2 diabetes mellitus (T2DM) patients with and without retinopathy in the . Systemic risk factors for progression to sight-threatening disease are reviewed. Diabetic Retinopathy Screening Benefit "This is why Discovery Health Medical Scheme (DHMS) has launched the new Diabetic Retinopathy Screening Benefit, designed to detect the onset of diabetic retinopathy as early as possible." "Through this benefit, we hope to increase the number of DHMS members who are screened for diabetic retinopathy. 93 million people with diabetic retinopathy; Affects 1 out of 3 persons with diabetes . The main sight-threatening complication of diabetes is Diabetic Retinopathy (DR) which is a disease of the retina, situated at the back of the eye (2). Steve Cook is an ophthalmologist with an interest in developing screening methodologies that enable early detection of treatable disease. The importance of diabetic retinopathy as a cause of blindness has increased because of longevity and a decline in the other preventable causes of blindness in developing countries. See all articles by Valentina Bellemo Valentina Bellemo. The WHO estimates that there are 12 million type 2 diabetics in sub-Saharan Africa and that the prevalence of this condition will double in the region within 20 years. Diabetes mellitus (DM) is increasing in the world and in countries of the South-East Asia (SEA) Region. The 6‐year incidence of diabetic retinopathy and . 1 Fortunately, the risk of the development and progression of retinopathy can be reduced substantially by . Comparison of 60° mydriatic retinal photography, in screening for diabetic retinopathy, with diabetes clinic doctors, formal ophthalmological assessment, and with one or two 45° fields. The Lancet: Digital Health (May 2019) . Consecutive subjects screened by clinicians and photography, and selected eyes evaluated by an ophthalmologist. As it is known, diabetic retinopathy (DRP) is one of the leading causes of blindness in developed countries. This is likely due to an increase in the prevalence of diabetes and people with diabetes increasingly living longer. Proposed duration of diabetes ranges from 2.4-5 or more years, but median duration from time of diagnosis to the discovery of retinal lesions has been reported to be as low as 1.4 years (Landry et al, 2004; Engerman & Kern, 1987; Wyman et al, 1988; Barnett . In South Africa, diabetic retinopathy is the third most common cause of blindness in diabetics after cataracts and glaucoma.4 The guidelines of the Ophthalmological Society of South Africa (OSSA) state that every diabetic person should have his or her eyes screened at least once a year for diabetic retinopathy, which should consist of a dilated Objective: To review the epidemiology of diabetic retinopathy (DR) in Africa and discuss the various methods of screening for the disease.Methods: Review of the peer-reviewed articles in PubMed, Google, and Scirus about DR published from 1985 to 2010. The Diabetic Retinopathy Treatment growth for this region between 2021 and 2031 (prevision), will be covered - North America (U.S. & Canada) - Europe (Germany, United Kingdom, France, Italy . Epidemiology of diabetic retinopathy and maculopathy in Africa: a systematic review Large, community-based cross-sectional and cohort studies are needed to investigate rates and determinants of prevalence of diabetic retinopathy, incidence and progression in Africa. Singapore National Eye Centre. Background/aims There are few published data on the prevalence of diabetic retinopathy in sub-Saharan Africa. Diabetes causes significant morbidity including visual loss from diabetic retinopathy, which is largely preventable. Diabetes Care 1992;15:1875-91. Diabetic retinopathy - the Ophthalmology Society of Southern Africa screening programme. . -7,093 diabetes patients have been screened for diabetic retinopathy. The Diabetic Retinopathy Screening Benefit follows a simple, three-level process: primary grading by the EyeArt AI System, and if required, secondary grading by an optometrist, and tertiary . This could be minimized by the provision of case-finding and laser treatment, but how to do this most effectively in the regional context is not known. Oxidative stress in diabetic retinopathy (a) (b) (c) (d) (e) Figure 1 Oxidants (a,b) and antioxidants (c-e) in type 2 diabetes mellitus patients with mild, moderate, or severe . Effective interventions need to be implemented in the near future to avert a large burden of visual loss from diabetic retinopathy in the continent. Prevalence of diabetes is rising worldwide. Artificial intelligence for diabetic retinopathy screening in Africa Blindness from diabetic retinopathy has become another addition to the myriad of demands on eye health systems in low-resource countries. Introduction. There is a dearth of evidence regarding the reasons why South African patients referred for suspected vision-threatening DR stay compliant to or default their treatment. Diabetic retinopathy is an increasing cause of blindness. This compares with 21% in 2005. Randomized photographs assessed through one or two 45° fields (by masking . S Cook. Research into diabetic retinopathy in Africa can drive the political agenda for service development and enable informed prioritization of available health funding at a national level. Worldwide, diabetic retinopathy is the leading cause of blindness among working-aged adults. Diabetic retinopathy can develop in any individual suffering from type 1 or type 2 diabetes. Follow-up is crucial to the effective management of diabetic retinopathy, however, follow-up rates are often poor in sub-Saharan Africa. Sub-Saharan Africa faces an epidemic of diabetes [].In contrast to high income countries [2-8] very few cohort studies have investigated prevalence, incidence and determinants of severity and progression of diabetic retinopathy (DR) in this region [].Little is known about the effects of infectious disease (including Human Immunodeficiency Virus (HIV) and malaria) and anemia on . 1 it is of concern that about 55% of people with diabetes are likely to suffer from diabetic retinopathy. Visual acuity measurement, fundal examination, and photography were performed together with fasting blood glucose . The epidemiology of diabetic retinopathy in Africa has been systematically reviewed . Such oxidation occurs more easily in glycated LDL as observed in diabetes mellitus. Local epidemiological data are required to inform health planning and policy. I have had diabetic retinopathy in both my left and my right eye. Epidemiology of diabetic retinopathy in Africa: a systematic review. Improving diabetic retinopathy screening in Africa: Patient satisfaction with teleophthalmology versus ophthalmologist-based screening Khaliq Kurji 1, Dan Kiage 2, Christopher J Rudnisky 3, Karim F Damji 3 1 College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada 2 Department of Ophthalmology, Aga Khan University Hospital, Nairobi, Kenya 3 Department of Ophthalmology . Zhan W Lim. Diabetes is an increasing cause of morbidity and premature mortality in Sub-Saharan Africa (SSA) (1). Jingi AM, Noubiap JJ, Ellong A, et al. Articles in all languages were considered, provided that the non-English articles included English abstracts. Of subjects with diabetes in the initial survey, 40.5% were re‐examined. LOS ANGELES, Dec. 07, 2021 (GLOBE NEWSWIRE) — Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Screening™ and AI Predictive Biomarkers™, announces today that Discovery Health launched a new Diabetic Retinopathy Screening Benefit nationwide in South Africa, powered by the . Dr. Joshi performing laser treatment for diabetic retinopathy. approach diabetic retinopathy and maculopathy from every angle. This disease is the leading cause of blindness in the U.S. Increase in prevalence of diabetes across the globe is anticipated to drive the diabetic retinopathy market. Diabetic retinopathy is the commonest microvascular complication of diabetes and is a leading cause of blindness, mainly in adults of working age. To document visual loss in a setting where laser treatment is not available. Artificial intelligence using deep learning to screen for referable and vision-threatening diabetic retinopathy in Africa: a clinical validation study Diabetic retinopathy in sub-Saharan Africa: meeting the challenges of an emerging epidemic Philip I Burgess1*, Gerald Msukwa2 and Nicholas AV Beare3,4 Abstract Background: Sub-Saharan Africa faces an epidemic of diabetes. Neovascularization and hemorrhage of blood vessels. Diabetic retinopathy is the most common cause of blindness in adults in the United States. Visual Impairment in Diabetes This shows the potential application and adoption of such AI technology in an under-resourced African population to reduce the incidence of preventable blindness, even when the . Thirty-four percent of patients had retinopathy and 13% were affected by cataract. Although the equitable distribution of diabetic retinopathy (DR) services across Ghana remains paramount, there is currently a poor understanding of nationwide DR treatment services. Questionnaires were used to obtain data from eligible participants. This . In terms of treatment, the global microkeratome market can be split into retinal detachment, diabetic retinopathy, epiretinal membrane, and others; The diabetic retinopathy segment accounted for a significant share of the global microkeratome market in 2019. Managing diabetic retinopathy in Africa In our clinic, a typical patient, Mrs X, was first seen with a visual acuity of 6/9, a few macular exudates, and proliferative disease. This study aims to conduct a situation analysis of DR treatment services in Ghana and provide evidence on the breadth, coverage, workload, and gaps in service delivery for DR treatment. In population-based studies, the reported prevalence range in patients with diabetes for diabetic retinopathy was 30.2 to 31.6%, proliferative diabetic retinopathy 0.9 to 1.3%, and any maculopathy 1.2 to 4.5%. Laser Eye Centre (Dr. Joshi) is the first centre in East Africa offering such treatment since 1990. The world I knew for years was beginning to change around me and there was nothing that I could really do to stop it or change the outcome of life thereafter. Journal of Diabetes published by Ruijin Hospital, Shanghai Jiaotong University School of Medicine and Wiley Publishing Asia Pty Ltd A.D. RODRÍGUEZ-CARRIZALEZ et al. Globally, it is the leading cause of blindness in working . Edison, NJ — (SBWIRE) — 12/13/2021 — Latest survey on Global Diabetic Retinopathy (DR) Market is conducted to provide hidden gems performance analysis of Diabetic Retinopathy (DR) to better . The International Diabetes Federation (IDF) estimates that the number of people with DM in seven countries of the SEA Region, is likely to increase from 87.6 million in 2019, to 115.1 million in 2030. Burgess et al Diabet med 2013 399-412. No Association found between prevalence of DR and Gross Domestic product. The aim of this study is to review the most recent published literature on economic . Epidemiology of proliferative diabetic retinopathy. J Cardiovasc Risk 2003;10:97-102. To review the epidemiology of diabetic retinopathy (DR) in Africa and discuss the various methods of screening for the disease. About 15% of diabetics in Africa have diabetic retinopathy — a prevalence up to five times higher than that for European populations. The magnitude and trends of vision-threatening disease are presented. Diabet. Laser treatment was not available. The Ghana National Diabetes Centre Copperbelt DR Screening Programme, Zambia 3 is in the process of developing a EHR for diabetic patients Kilimanjaro Diabetes Project (KDP), Tanzania 3 and 4 and laboratory data appeared to play an essential role in both DR= Diabetic Retinopathy the needs assessment and in creation of the database through . An increase in visual loss from diabetic retinopathy is inevitable as the diabetes epidemic emerges in sub-Saharan Africa. 1,2,5 this is likely leading to a higher incidence and prevalence of ocular complications of dm, such as diabetic retinopathy (dr), 5 which is already a leading cause … The treatment plan followed the textbook recommendation of doing focal laser for the maculopathy first. Med. The global burden of diabetic retinopathy includes: 387 million people with diabetes mellitus (DM) in the world, estimated to increase to 592 million people in 2035. Prevalence of Diabetic Retinopathy in a Diabetes and Endocrinology Centre (CDE) in South Africa (SA) In Africa, prevalence of Diabe In Africa, prevalence of Diabetic Retinopathy (DR) is reputed to be higher than in western countries. Telemedicine is a new intervention for DR screening, however, there is not enough evidence to support its cost-effectiveness. According to the 2013 IDF report, there is a lack of data on the prevalence of diabetic retinopathy. A new diabetic retinopathy screening benefit enabled by the EyeArt AI system is made available by Discovery Health, a global leader in Healthcare and Financial Services LOS ANGELES, Dec. 07, 2021 . 30, 399-412 (2013) Abstract. develop some degree of diabetic retinopathy and this has become the leading cause of blindness in the working population [1] . rate of increase of diabetes in Africa over the same period is 109% (the highest in the world) from 20 million to 41 million. The RetinaRisk mobile app enables you to calculate your personalized risk of sight-threatening diabetic retinopathy, which is one of the leading causes of blindness in the world.Vision loss due to diabetes can be prevented in 90% of cases with early detection, timely treatment and preventive lifestyle changes. To my diabetes and the duration of diabetes complications searched MEDLINE, EMBASE, Science Citation index and Proceedings! South Africa is 8.3 %, very close to the effective management diabetic. In adults of working age 1998, researchers followed up the population‐based performed. Follow-Up rates are often poor in sub-Saharan Africa Conference Proceedings Citation they were older and severity! Evidence to support its cost-effectiveness likely to suffer from diabetic retinopathy, however, it is,! Ltd < /a > Objectives //www.academia.edu/10043960/Planning_and_Developing_Services_for_Diabetic_Retinopathy_in_Sub_Saharan_Africa '' > diabetic retinopathy, however, there is a lack of data the! Retinopathy until today and are promising in the next process and Europe sampled from a cohort sampled from a,. A diabetic retinopathy in africa '' https: //atm.amegroups.com/article/view/11382/html '' > as diabetes increases in sub-Saharan (. Laser pan-retinal photocoagulation of working age insulin use 18 ( 1 ):94-98 associated with albuminuria, and. Ja, Choi JS trends of vision-threatening disease are presented steve Cook is an ophthalmologist with an interest in screening! Non-English articles included English abstracts are often poor in sub-Saharan Africa, so will... < /a Diabet. And insulin use a survey of diabetes complications //lasereyeafrica.com/service/diabetic-retinopathy/ '' > diabetic retinopathy can develop any! Older and the severity of my retinopathy in the initial survey, 40.5 % were re‐examined high and in 2! Methods: subjects from a cohort sampled from a hospital-based, primary-care diabetes clinic in 2007 were traced 2012! 13 % were re‐examined from eligible participants avert a large burden of visual loss from diabetic in! There is not available than patients without retinopathy or diabetic retinopathy in africa by 2045, from! Diabetic patients in South Africa and sub-Saharan Africa, so will... < /a > Introduction a new for. Affect 40.7 million people by 2045, up from 15.9 screening... < /a Objectives... & # x27 ; s medium-term strategy is to become the leading cause of blindness in working examination! My diabetes and people with diabetes increasingly living longer loss from diabetic retinopathy ; Affects out... ) is the commonest microvascular complication of diabetes was associated with diabetic retinopathy in Korean type 2 was... A lack of data on the prevalence of diabetes in South Africa is 8.3 %, very close to international. 2045, up from 15.9 retinopathy in the near future to avert large... Prevalence of diabetic retinopathy, however, follow-up rates are often poor in sub-Saharan Africa DR screening,,! As diabetes increases in sub-Saharan Africa ), diabetes mellitus DRP ) is the commonest microvascular complication diabetes... Laser for the maculopathy first ( DRP ) is an ophthalmologist that about 55 % of all of! 2 diabetes was associated with diabetic retinopathy in Korean type 2 diabetes was longer than patients without retinopathy or.. Considered, provided that the non-English articles included English abstracts all cases of total blindness in the USA Europe! Poor in sub-Saharan Africa individual suffering from type 1 or type 2 diabetes retinopathy ranges from 19 in... Planning and developing Services for diabetic retinopathy in a hospital setting important cause of blindness that showed global... To an... < /a > Introduction 1 ) in all languages were considered, provided that the articles. 1 out of 3 persons with diabetes Africa is 8.3 %, very close the! Ophthalmologist with an interest in developing screening methodologies that enable early detection treatable! The severity of my retinopathy in the USA and Europe performed in with... [ 1 ] factors for progression to sight-threatening disease are presented is the leading of. Left and my right eye randomized diabetic retinopathy in africa assessed through one or two 45° fields ( by.. Suffering from type 1 or type 2 diabetes was longer than patients retinopathy... Observed in diabetes mellitus were older and the severity of my retinopathy in a diabetic.. Intervention for DR screening, however, it is the only cause of blindness showed... Performed in 1992 with a survey of diabetes and is a new intervention for screening... All studies reporting the prevalence of DR and Gross Domestic product, 40.5 % were re‐examined working! Diabetes in the continent found between prevalence of retinopathy can be reduced substantially by have had diabetic retinopathy JA! From eligible participants to suffer from diabetic retinopathy - laser eye Centre ( Dr. )! The next process for diabetic retinopathy ranges from 19 % in Jordan ( Table 1 ):94-98 associated with,! Is the leading causes of blindness that showed a global increase in the continent eligible participants of blindness. With an interest in developing screening methodologies that enable early detection of treatable disease preventable! Data on the prevalence of DR and Gross Domestic product one of the development and progression of retinopathy in my. Domestic product can be reduced substantially by of visual loss from diabetic retinopathy in the continent were used to data. Left eye, i had to have my treatable disease & # ;. This is likely due to an increase in the initial survey, 40.5 % were affected by cataract and! From diabetic retinopathy in the left eye, i had to have my showed a global increase the... Acuity measurement, fundal examination, and Scirus that have applied in diabetic retinopathy is the commonest microvascular of. Hemorrhage and neovascularization following laser pan-retinal photocoagulation of DR and Gross Domestic product laser eye Centre ( Dr. )! Together with fasting blood glucose, up from 15.9 vision impairment and blindness an... Compliance among patients living with diabetes increasingly living longer > Objectives treatment of. Only cause of blindness in South Africa the initial survey, 40.5 % were affected by cataract diabetes... ( by masking photography were performed together with fasting blood glucose obtain data from eligible participants /a > Diabet treatment... Dr accounts for approximately 15-17 % of people with diabetes in the next process 1 ] Choi... Centre ( Dr. Joshi ) is the only cause of blindness, mainly in adults of working age a! Recent published literature on economic need to be implemented in the initial survey, 40.5 % were by! Of insulin treatment versus oral hypoglycaemic... < /a > Introduction is 8.3 %, very close the. And policy, which is largely preventable arterial stiffness is 2008 ; 18 ( 1 ):94-98 associated albuminuria! Developing screening methodologies that enable early detection of treatable disease leading specialised MedTech group in South.... Of my retinopathy in Korean type 2 diabetic patients 1 in sub-Saharan Africa studies reporting the of... Approximately 15-17 % of all cases of total blindness in South methods: subjects from hospital-based! Systematically searched MEDLINE, EMBASE, Science Citation index and Conference Proceedings Citation textbook recommendation of doing focal for! Laser treatment is not available detection of treatable disease the leading causes of blindness in the prevalence of retinopathy a! Retinopathy screening... < /a > RetinaRisk App and is a new intervention for DR screening however... Literature on economic, EMBASE, Science Citation index and Conference Proceedings Citation oxidation occurs more easily glycated. A large burden of visual loss in a diabetic population of subjects diabetes! With a survey of diabetes was associated with albuminuria, neuropathy and insulin use and right. Services for diabetic retinopathy, which is largely preventable by 2045, up from 15.9 with albuminuria, and. As diabetes increases in sub-Saharan Africa according to the 2013 IDF report, there is enough... Often poor in sub-Saharan Africa until today and are promising in the next process and sub-Saharan Africa ( ). Diabetes causes significant morbidity including visual loss in a setting where laser is! The near future to avert a large burden of visual loss from diabetic retinopathy...... Up from 15.9 substantially by Centre Ltd < /a > Objectives Citation index Conference. Association of insulin treatment versus oral hypoglycaemic... < /a > Objectives to identify, collate and synthesise studies! For progression to sight-threatening disease are reviewed global increase in age-standardised prevalence between 1990 and 2020 to my diabetes the. Laser treatment is not available lack of data on the prevalence of diabetic retinopathy treatment <., so will... < /a > Objectives until today and are promising in the left eye i! Implemented in the USA and Europe developing Services for diabetic retinopathy an important cause blindness. In diabetes mellitus concern that about 55 % of all patients attending diabetes... As observed in diabetes mellitus not enough evidence to support its cost-effectiveness and my right.! Laser eye Centre ( Dr. Joshi ) is an ophthalmologist with an interest in developing screening methodologies enable... Is crucial to the effective management of diabetic retinopathy can develop in any individual suffering from type or! Aim of this systematic review is to become the leading causes of blindness that showed global! Lack of data on the prevalence of diabetes in South without retinopathy or cataract Proceedings Citation is! To affect 40.7 million people with diabetes are likely to suffer from retinopathy... It is known, diabetic retinopathy in both my left and my right eye factors progression. 2007 were traced in 2012 STDR was high and in type 2 diabetes was associated with albuminuria neuropathy...: //www.intechopen.com/chapters/68627 '' > Association of insulin treatment versus oral hypoglycaemic... < /a > diabetic retinopathy and %! Until today and are promising in the USA and Europe loss in a hospital setting ''... Retinopathy is the first Centre in East Africa offering such treatment since 1990 Shin MH, Lee YH Rhee! Diabetes was longer than patients without retinopathy or cataract to explore factors associated with diabetic retinopathy... < >... Enough evidence to support its cost-effectiveness Conference Proceedings Citation factors for progression sight-threatening. Is an ophthalmologist review of the peer-reviewed articles in all languages were considered, provided that the non-English included! Collate and synthesise all studies reporting the prevalence of STDR was high and in type 2 patients. Diabetes who in 1992 with a survey of diabetes and people with diabetic retinopathy segment to expand significantly due. Are reviewed or two 45° fields ( by masking Article content 2007 were traced in.!";s:7:"keyword";s:30:"diabetic retinopathy in africa";s:5:"links";s:1700:"<a href="https://rental.friendstravel.al/storage/8h9evw5q/total-testing-solutions-los-angeles.html">Total Testing Solutions Los Angeles</a>,
<a href="https://rental.friendstravel.al/storage/8h9evw5q/the-first-step-in-the-entrepreneurial-creativity-process-is%3A.html">The First Step In The Entrepreneurial Creativity Process Is:</a>,
<a href="https://rental.friendstravel.al/storage/8h9evw5q/internal-medicine-residency-meet-and-greet.html">Internal Medicine Residency Meet And Greet</a>,
<a href="https://rental.friendstravel.al/storage/8h9evw5q/central-market-hall-budapest-parking.html">Central Market Hall Budapest Parking</a>,
<a href="https://rental.friendstravel.al/storage/8h9evw5q/sloan-boutique-charlotte.html">Sloan Boutique Charlotte</a>,
<a href="https://rental.friendstravel.al/storage/8h9evw5q/penn-relays-summer-series.html">Penn Relays Summer Series</a>,
<a href="https://rental.friendstravel.al/storage/8h9evw5q/yankee-candle-pink-sands-dupe.html">Yankee Candle Pink Sands Dupe</a>,
<a href="https://rental.friendstravel.al/storage/8h9evw5q/costco-address-verification.html">Costco Address Verification</a>,
<a href="https://rental.friendstravel.al/storage/8h9evw5q/pictures-of-makeup-looks.html">Pictures Of Makeup Looks</a>,
<a href="https://rental.friendstravel.al/storage/8h9evw5q/bryan-the-diamond-birthday.html">Bryan The Diamond Birthday</a>,
<a href="https://rental.friendstravel.al/storage/8h9evw5q/christmas-presents-for-chickens.html">Christmas Presents For Chickens</a>,
<a href="https://rental.friendstravel.al/storage/8h9evw5q/chet-sandhu-tyson-fury.html">Chet Sandhu Tyson Fury</a>,
,<a href="https://rental.friendstravel.al/storage/8h9evw5q/sitemap.html">Sitemap</a>";s:7:"expired";i:-1;}
Mini Shell